203 related articles for article (PubMed ID: 23958921)
1. Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance.
Hillengass J; Weber MA; Kilk K; Listl K; Wagner-Gund B; Hillengass M; Hielscher T; Farid A; Neben K; Delorme S; Landgren O; Goldschmidt H
Leukemia; 2014 Jan; 28(1):174-8. PubMed ID: 23958921
[TBL] [Abstract][Full Text] [Related]
2. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
[TBL] [Abstract][Full Text] [Related]
4. Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma.
Hillengass J; Ritsch J; Merz M; Wagner B; Kunz C; Hielscher T; Laue H; Bäuerle T; Zechmann CM; Ho AD; Schlemmer HP; Goldschmidt H; Moehler TM; Delorme S
Br J Haematol; 2016 Jul; 174(1):127-35. PubMed ID: 26991959
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
6. Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma).
Van Den Berghe T; Verstraete KL; Lecouvet FE; Lejoly M; Dutoit J
Skeletal Radiol; 2022 Jan; 51(1):101-122. PubMed ID: 34523007
[TBL] [Abstract][Full Text] [Related]
7. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?
Spira D; Weisel K; Brodoefel H; Schulze M; Kaufmann S; Horger M
Acad Radiol; 2012 Jan; 19(1):89-94. PubMed ID: 22142681
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; Rajkumar SV
Curr Hematol Malig Rep; 2010 Apr; 5(2):62-9. PubMed ID: 20425398
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management.
Hillengass J; Moehler T; Hundemer M
Recent Results Cancer Res; 2011; 183():113-31. PubMed ID: 21509683
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S
Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311
[TBL] [Abstract][Full Text] [Related]
11. Smoldering multiple myeloma and monoclonal gammopathy of undetermined significance.
Bladé J; Rosiñol L
Curr Treat Options Oncol; 2006 May; 7(3):237-45. PubMed ID: 16615879
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Diffuse Bone Marrow Infiltration Pattern in Monoclonal Plasma Cell Diseases by Quantitative Whole-body Magnetic Resonance Imaging.
Sun M; Cheng J; Ren C; Zhang Y; Li Y; Wang L; Zhang S; Lin L
Acad Radiol; 2022 Apr; 29(4):490-500. PubMed ID: 34362664
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathy of undetermined significance: a new proposal of workup.
Mangiacavalli S; Cocito F; Pochintesta L; Pascutto C; Ferretti V; Varettoni M; Zappasodi P; Pompa A; Landini B; Cazzola M; Corso A
Eur J Haematol; 2013 Oct; 91(4):356-60. PubMed ID: 23859528
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology.
Hillengass J; Bäuerle T; Bartl R; Andrulis M; McClanahan F; Laun FB; Zechmann CM; Shah R; Wagner-Gund B; Simon D; Heiss C; Neben K; Ho AD; Schlemmer HP; Goldschmidt H; Delorme S; Stieltjes B
Br J Haematol; 2011 Jun; 153(6):721-8. PubMed ID: 21517815
[TBL] [Abstract][Full Text] [Related]
15. [Multiple myeloma: current recommendations for imaging].
Hillengass J; Delorme S
Radiologe; 2012 Apr; 52(4):360-5. PubMed ID: 22441560
[TBL] [Abstract][Full Text] [Related]
16. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
[TBL] [Abstract][Full Text] [Related]
18. The "Undetermined Significance" of
Treglia G; Bertagna F; Albano D
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441062
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.
Hillengass J; Fechtner K; Weber MA; Bäuerle T; Ayyaz S; Heiss C; Hielscher T; Moehler TM; Egerer G; Neben K; Ho AD; Kauczor HU; Delorme S; Goldschmidt H
J Clin Oncol; 2010 Mar; 28(9):1606-10. PubMed ID: 20177023
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
